nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—Coma—Epirubicin—sarcoma	0.00367	0.00367	CcSEcCtD
Disopyramide—Discomfort—Dactinomycin—sarcoma	0.00364	0.00364	CcSEcCtD
Disopyramide—Confusional state—Thiotepa—sarcoma	0.00359	0.00359	CcSEcCtD
Disopyramide—Hypoaesthesia—Etoposide—sarcoma	0.00358	0.00358	CcSEcCtD
Disopyramide—Vision blurred—Mitoxantrone—sarcoma	0.00355	0.00355	CcSEcCtD
Disopyramide—Oedema—Dactinomycin—sarcoma	0.00353	0.00353	CcSEcCtD
Disopyramide—Blood urea increased—Doxorubicin—sarcoma	0.00351	0.00351	CcSEcCtD
Disopyramide—Ill-defined disorder—Mitoxantrone—sarcoma	0.00349	0.00349	CcSEcCtD
Disopyramide—Thrombocytopenia—Thiotepa—sarcoma	0.00349	0.00349	CcSEcCtD
Disopyramide—Vertigo—Vincristine—sarcoma	0.00347	0.00347	CcSEcCtD
Disopyramide—Thrombocytopenia—Dactinomycin—sarcoma	0.00346	0.00346	CcSEcCtD
Disopyramide—Skin disorder—Thiotepa—sarcoma	0.00346	0.00346	CcSEcCtD
Disopyramide—Dry eye—Doxorubicin—sarcoma	0.00343	0.00343	CcSEcCtD
Disopyramide—Malaise—Mitoxantrone—sarcoma	0.0034	0.0034	CcSEcCtD
Disopyramide—Coma—Doxorubicin—sarcoma	0.0034	0.0034	CcSEcCtD
Disopyramide—Anorexia—Thiotepa—sarcoma	0.00339	0.00339	CcSEcCtD
Disopyramide—Anorexia—Dactinomycin—sarcoma	0.00337	0.00337	CcSEcCtD
Disopyramide—Cardiac failure congestive—Epirubicin—sarcoma	0.00322	0.00322	CcSEcCtD
Disopyramide—Chest pain—Mitoxantrone—sarcoma	0.00321	0.00321	CcSEcCtD
Disopyramide—Paraesthesia—Thiotepa—sarcoma	0.0032	0.0032	CcSEcCtD
Disopyramide—Discomfort—Mitoxantrone—sarcoma	0.00317	0.00317	CcSEcCtD
Disopyramide—Somnolence—Thiotepa—sarcoma	0.00316	0.00316	CcSEcCtD
Disopyramide—Oedema—Vincristine—sarcoma	0.00316	0.00316	CcSEcCtD
Disopyramide—Dyspepsia—Thiotepa—sarcoma	0.00313	0.00313	CcSEcCtD
Disopyramide—Confusional state—Mitoxantrone—sarcoma	0.0031	0.0031	CcSEcCtD
Disopyramide—Decreased appetite—Thiotepa—sarcoma	0.00309	0.00309	CcSEcCtD
Disopyramide—Thrombocytopenia—Vincristine—sarcoma	0.00309	0.00309	CcSEcCtD
Disopyramide—Oedema—Mitoxantrone—sarcoma	0.00307	0.00307	CcSEcCtD
Disopyramide—Decreased appetite—Dactinomycin—sarcoma	0.00307	0.00307	CcSEcCtD
Disopyramide—Fatigue—Thiotepa—sarcoma	0.00307	0.00307	CcSEcCtD
Disopyramide—Dysgeusia—Etoposide—sarcoma	0.00307	0.00307	CcSEcCtD
Disopyramide—Hyperhidrosis—Vincristine—sarcoma	0.00305	0.00305	CcSEcCtD
Disopyramide—Fatigue—Dactinomycin—sarcoma	0.00305	0.00305	CcSEcCtD
Disopyramide—Pain—Thiotepa—sarcoma	0.00304	0.00304	CcSEcCtD
Disopyramide—Constipation—Thiotepa—sarcoma	0.00304	0.00304	CcSEcCtD
Disopyramide—Shock—Mitoxantrone—sarcoma	0.00302	0.00302	CcSEcCtD
Disopyramide—Pain—Dactinomycin—sarcoma	0.00302	0.00302	CcSEcCtD
Disopyramide—Thrombocytopenia—Mitoxantrone—sarcoma	0.00301	0.00301	CcSEcCtD
Disopyramide—Anorexia—Vincristine—sarcoma	0.00301	0.00301	CcSEcCtD
Disopyramide—Cardiac failure—Epirubicin—sarcoma	0.00299	0.00299	CcSEcCtD
Disopyramide—Hypoglycaemia—Epirubicin—sarcoma	0.00299	0.00299	CcSEcCtD
Disopyramide—Skin disorder—Mitoxantrone—sarcoma	0.00299	0.00299	CcSEcCtD
Disopyramide—Cardiac failure congestive—Doxorubicin—sarcoma	0.00298	0.00298	CcSEcCtD
Disopyramide—Hyperhidrosis—Mitoxantrone—sarcoma	0.00297	0.00297	CcSEcCtD
Disopyramide—Hypotension—Vincristine—sarcoma	0.00295	0.00295	CcSEcCtD
Disopyramide—Feeling abnormal—Thiotepa—sarcoma	0.00293	0.00293	CcSEcCtD
Disopyramide—Anorexia—Mitoxantrone—sarcoma	0.00293	0.00293	CcSEcCtD
Disopyramide—Diplopia—Epirubicin—sarcoma	0.00292	0.00292	CcSEcCtD
Disopyramide—Feeling abnormal—Dactinomycin—sarcoma	0.00291	0.00291	CcSEcCtD
Disopyramide—Ill-defined disorder—Etoposide—sarcoma	0.00291	0.00291	CcSEcCtD
Disopyramide—Hypotension—Mitoxantrone—sarcoma	0.00287	0.00287	CcSEcCtD
Disopyramide—Insomnia—Vincristine—sarcoma	0.00285	0.00285	CcSEcCtD
Disopyramide—Paraesthesia—Vincristine—sarcoma	0.00283	0.00283	CcSEcCtD
Disopyramide—Urticaria—Thiotepa—sarcoma	0.00283	0.00283	CcSEcCtD
Disopyramide—Malaise—Etoposide—sarcoma	0.00283	0.00283	CcSEcCtD
Disopyramide—Vertigo—Etoposide—sarcoma	0.00281	0.00281	CcSEcCtD
Disopyramide—Body temperature increased—Thiotepa—sarcoma	0.00281	0.00281	CcSEcCtD
Disopyramide—Body temperature increased—Dactinomycin—sarcoma	0.00279	0.00279	CcSEcCtD
Disopyramide—Cardiac arrest—Epirubicin—sarcoma	0.00277	0.00277	CcSEcCtD
Disopyramide—Cardiac failure—Doxorubicin—sarcoma	0.00276	0.00276	CcSEcCtD
Disopyramide—Hypoglycaemia—Doxorubicin—sarcoma	0.00276	0.00276	CcSEcCtD
Disopyramide—Paraesthesia—Mitoxantrone—sarcoma	0.00276	0.00276	CcSEcCtD
Disopyramide—Loss of consciousness—Etoposide—sarcoma	0.00275	0.00275	CcSEcCtD
Disopyramide—Decreased appetite—Vincristine—sarcoma	0.00274	0.00274	CcSEcCtD
Disopyramide—Dyspnoea—Mitoxantrone—sarcoma	0.00274	0.00274	CcSEcCtD
Disopyramide—Somnolence—Mitoxantrone—sarcoma	0.00273	0.00273	CcSEcCtD
Disopyramide—Blood creatinine increased—Epirubicin—sarcoma	0.00273	0.00273	CcSEcCtD
Disopyramide—Fatigue—Vincristine—sarcoma	0.00272	0.00272	CcSEcCtD
Disopyramide—Dyspepsia—Mitoxantrone—sarcoma	0.00271	0.00271	CcSEcCtD
Disopyramide—Pain—Vincristine—sarcoma	0.0027	0.0027	CcSEcCtD
Disopyramide—Constipation—Vincristine—sarcoma	0.0027	0.0027	CcSEcCtD
Disopyramide—Diplopia—Doxorubicin—sarcoma	0.0027	0.0027	CcSEcCtD
Disopyramide—Decreased appetite—Mitoxantrone—sarcoma	0.00267	0.00267	CcSEcCtD
Disopyramide—Chest pain—Etoposide—sarcoma	0.00267	0.00267	CcSEcCtD
Disopyramide—Abdominal pain upper—Epirubicin—sarcoma	0.00266	0.00266	CcSEcCtD
Disopyramide—Hypokalaemia—Epirubicin—sarcoma	0.00265	0.00265	CcSEcCtD
Disopyramide—Fatigue—Mitoxantrone—sarcoma	0.00265	0.00265	CcSEcCtD
Disopyramide—Discomfort—Etoposide—sarcoma	0.00264	0.00264	CcSEcCtD
Disopyramide—Pain—Mitoxantrone—sarcoma	0.00263	0.00263	CcSEcCtD
Disopyramide—Constipation—Mitoxantrone—sarcoma	0.00263	0.00263	CcSEcCtD
Disopyramide—Confusional state—Etoposide—sarcoma	0.00258	0.00258	CcSEcCtD
Disopyramide—Muscular weakness—Epirubicin—sarcoma	0.00257	0.00257	CcSEcCtD
Disopyramide—Cardiac arrest—Doxorubicin—sarcoma	0.00257	0.00257	CcSEcCtD
Disopyramide—Asthenia—Thiotepa—sarcoma	0.00255	0.00255	CcSEcCtD
Disopyramide—Abdominal distension—Epirubicin—sarcoma	0.00254	0.00254	CcSEcCtD
Disopyramide—Asthenia—Dactinomycin—sarcoma	0.00253	0.00253	CcSEcCtD
Disopyramide—Feeling abnormal—Mitoxantrone—sarcoma	0.00253	0.00253	CcSEcCtD
Disopyramide—Blood creatinine increased—Doxorubicin—sarcoma	0.00253	0.00253	CcSEcCtD
Disopyramide—Pruritus—Thiotepa—sarcoma	0.00252	0.00252	CcSEcCtD
Disopyramide—Thrombocytopenia—Etoposide—sarcoma	0.0025	0.0025	CcSEcCtD
Disopyramide—Body temperature increased—Vincristine—sarcoma	0.0025	0.0025	CcSEcCtD
Disopyramide—Skin disorder—Etoposide—sarcoma	0.00248	0.00248	CcSEcCtD
Disopyramide—Hyperhidrosis—Etoposide—sarcoma	0.00247	0.00247	CcSEcCtD
Disopyramide—Abdominal pain upper—Doxorubicin—sarcoma	0.00246	0.00246	CcSEcCtD
Disopyramide—Hypokalaemia—Doxorubicin—sarcoma	0.00246	0.00246	CcSEcCtD
Disopyramide—Urticaria—Mitoxantrone—sarcoma	0.00244	0.00244	CcSEcCtD
Disopyramide—Anorexia—Etoposide—sarcoma	0.00244	0.00244	CcSEcCtD
Disopyramide—Diarrhoea—Thiotepa—sarcoma	0.00244	0.00244	CcSEcCtD
Disopyramide—Body temperature increased—Mitoxantrone—sarcoma	0.00243	0.00243	CcSEcCtD
Disopyramide—Diarrhoea—Dactinomycin—sarcoma	0.00242	0.00242	CcSEcCtD
Disopyramide—Hypotension—Etoposide—sarcoma	0.00239	0.00239	CcSEcCtD
Disopyramide—Muscular weakness—Doxorubicin—sarcoma	0.00238	0.00238	CcSEcCtD
Disopyramide—Dysuria—Epirubicin—sarcoma	0.00236	0.00236	CcSEcCtD
Disopyramide—Neutropenia—Epirubicin—sarcoma	0.00236	0.00236	CcSEcCtD
Disopyramide—Dizziness—Thiotepa—sarcoma	0.00235	0.00235	CcSEcCtD
Disopyramide—Abdominal distension—Doxorubicin—sarcoma	0.00235	0.00235	CcSEcCtD
Disopyramide—Pollakiuria—Epirubicin—sarcoma	0.00233	0.00233	CcSEcCtD
Disopyramide—Paraesthesia—Etoposide—sarcoma	0.0023	0.0023	CcSEcCtD
Disopyramide—Weight increased—Epirubicin—sarcoma	0.00229	0.00229	CcSEcCtD
Disopyramide—Dyspnoea—Etoposide—sarcoma	0.00228	0.00228	CcSEcCtD
Disopyramide—Somnolence—Etoposide—sarcoma	0.00227	0.00227	CcSEcCtD
Disopyramide—Asthenia—Vincristine—sarcoma	0.00226	0.00226	CcSEcCtD
Disopyramide—Vomiting—Thiotepa—sarcoma	0.00226	0.00226	CcSEcCtD
Disopyramide—Drowsiness—Epirubicin—sarcoma	0.00225	0.00225	CcSEcCtD
Disopyramide—Vomiting—Dactinomycin—sarcoma	0.00225	0.00225	CcSEcCtD
Disopyramide—Rash—Thiotepa—sarcoma	0.00224	0.00224	CcSEcCtD
Disopyramide—Dermatitis—Thiotepa—sarcoma	0.00224	0.00224	CcSEcCtD
Disopyramide—Headache—Thiotepa—sarcoma	0.00223	0.00223	CcSEcCtD
Disopyramide—Rash—Dactinomycin—sarcoma	0.00223	0.00223	CcSEcCtD
Disopyramide—Decreased appetite—Etoposide—sarcoma	0.00222	0.00222	CcSEcCtD
Disopyramide—Asthenia—Mitoxantrone—sarcoma	0.00221	0.00221	CcSEcCtD
Disopyramide—Fatigue—Etoposide—sarcoma	0.0022	0.0022	CcSEcCtD
Disopyramide—Constipation—Etoposide—sarcoma	0.00219	0.00219	CcSEcCtD
Disopyramide—Pain—Etoposide—sarcoma	0.00219	0.00219	CcSEcCtD
Disopyramide—Dysuria—Doxorubicin—sarcoma	0.00218	0.00218	CcSEcCtD
Disopyramide—Neutropenia—Doxorubicin—sarcoma	0.00218	0.00218	CcSEcCtD
Disopyramide—Diarrhoea—Vincristine—sarcoma	0.00216	0.00216	CcSEcCtD
Disopyramide—Pollakiuria—Doxorubicin—sarcoma	0.00215	0.00215	CcSEcCtD
Disopyramide—Weight increased—Doxorubicin—sarcoma	0.00212	0.00212	CcSEcCtD
Disopyramide—Nausea—Thiotepa—sarcoma	0.00211	0.00211	CcSEcCtD
Disopyramide—Feeling abnormal—Etoposide—sarcoma	0.00211	0.00211	CcSEcCtD
Disopyramide—Diarrhoea—Mitoxantrone—sarcoma	0.0021	0.0021	CcSEcCtD
Disopyramide—Nausea—Dactinomycin—sarcoma	0.0021	0.0021	CcSEcCtD
Disopyramide—Agranulocytosis—Epirubicin—sarcoma	0.0021	0.0021	CcSEcCtD
Disopyramide—Dizziness—Vincristine—sarcoma	0.00209	0.00209	CcSEcCtD
Disopyramide—Drowsiness—Doxorubicin—sarcoma	0.00208	0.00208	CcSEcCtD
Disopyramide—Bradycardia—Epirubicin—sarcoma	0.00205	0.00205	CcSEcCtD
Disopyramide—Urticaria—Etoposide—sarcoma	0.00203	0.00203	CcSEcCtD
Disopyramide—Body temperature increased—Etoposide—sarcoma	0.00202	0.00202	CcSEcCtD
Disopyramide—Hepatitis—Epirubicin—sarcoma	0.00202	0.00202	CcSEcCtD
Disopyramide—Hypoaesthesia—Epirubicin—sarcoma	0.00201	0.00201	CcSEcCtD
Disopyramide—Vomiting—Vincristine—sarcoma	0.00201	0.00201	CcSEcCtD
Disopyramide—Rash—Vincristine—sarcoma	0.00199	0.00199	CcSEcCtD
Disopyramide—Dermatitis—Vincristine—sarcoma	0.00199	0.00199	CcSEcCtD
Disopyramide—Headache—Vincristine—sarcoma	0.00198	0.00198	CcSEcCtD
Disopyramide—Vomiting—Mitoxantrone—sarcoma	0.00195	0.00195	CcSEcCtD
Disopyramide—Agranulocytosis—Doxorubicin—sarcoma	0.00194	0.00194	CcSEcCtD
Disopyramide—Rash—Mitoxantrone—sarcoma	0.00194	0.00194	CcSEcCtD
Disopyramide—Dermatitis—Mitoxantrone—sarcoma	0.00194	0.00194	CcSEcCtD
Disopyramide—Headache—Mitoxantrone—sarcoma	0.00193	0.00193	CcSEcCtD
Disopyramide—Bradycardia—Doxorubicin—sarcoma	0.0019	0.0019	CcSEcCtD
Disopyramide—Nausea—Vincristine—sarcoma	0.00187	0.00187	CcSEcCtD
Disopyramide—Hepatitis—Doxorubicin—sarcoma	0.00187	0.00187	CcSEcCtD
Disopyramide—Hypoaesthesia—Doxorubicin—sarcoma	0.00186	0.00186	CcSEcCtD
Disopyramide—Asthenia—Etoposide—sarcoma	0.00183	0.00183	CcSEcCtD
Disopyramide—Nausea—Mitoxantrone—sarcoma	0.00183	0.00183	CcSEcCtD
Disopyramide—Pruritus—Etoposide—sarcoma	0.00181	0.00181	CcSEcCtD
Disopyramide—Arrhythmia—Epirubicin—sarcoma	0.0018	0.0018	CcSEcCtD
Disopyramide—Diarrhoea—Etoposide—sarcoma	0.00175	0.00175	CcSEcCtD
Disopyramide—Flatulence—Epirubicin—sarcoma	0.00173	0.00173	CcSEcCtD
Disopyramide—Tension—Epirubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Disopyramide—Dysgeusia—Epirubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Disopyramide—Nervousness—Epirubicin—sarcoma	0.00171	0.00171	CcSEcCtD
Disopyramide—Dizziness—Etoposide—sarcoma	0.00169	0.00169	CcSEcCtD
Disopyramide—Arrhythmia—Doxorubicin—sarcoma	0.00167	0.00167	CcSEcCtD
Disopyramide—Vision blurred—Epirubicin—sarcoma	0.00166	0.00166	CcSEcCtD
Disopyramide—Ill-defined disorder—Epirubicin—sarcoma	0.00163	0.00163	CcSEcCtD
Disopyramide—Vomiting—Etoposide—sarcoma	0.00163	0.00163	CcSEcCtD
Disopyramide—Rash—Etoposide—sarcoma	0.00161	0.00161	CcSEcCtD
Disopyramide—Dermatitis—Etoposide—sarcoma	0.00161	0.00161	CcSEcCtD
Disopyramide—Headache—Etoposide—sarcoma	0.0016	0.0016	CcSEcCtD
Disopyramide—Flatulence—Doxorubicin—sarcoma	0.0016	0.0016	CcSEcCtD
Disopyramide—Tension—Doxorubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Disopyramide—Dysgeusia—Doxorubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Disopyramide—Malaise—Epirubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Disopyramide—Nervousness—Doxorubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Disopyramide—Vertigo—Epirubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Disopyramide—Syncope—Epirubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Disopyramide—Loss of consciousness—Epirubicin—sarcoma	0.00154	0.00154	CcSEcCtD
Disopyramide—Vision blurred—Doxorubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Disopyramide—Nausea—Etoposide—sarcoma	0.00152	0.00152	CcSEcCtD
Disopyramide—Ill-defined disorder—Doxorubicin—sarcoma	0.00151	0.00151	CcSEcCtD
Disopyramide—Chest pain—Epirubicin—sarcoma	0.0015	0.0015	CcSEcCtD
Disopyramide—Discomfort—Epirubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Disopyramide—Malaise—Doxorubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Disopyramide—Dry mouth—Epirubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Disopyramide—Vertigo—Doxorubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Disopyramide—Syncope—Doxorubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Disopyramide—Confusional state—Epirubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Disopyramide—Oedema—Epirubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Disopyramide—Loss of consciousness—Doxorubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Disopyramide—Shock—Epirubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Disopyramide—Thrombocytopenia—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Disopyramide—Skin disorder—Epirubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Disopyramide—Hyperhidrosis—Epirubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Disopyramide—Chest pain—Doxorubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Disopyramide—Discomfort—Doxorubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Disopyramide—Anorexia—Epirubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Disopyramide—Dry mouth—Doxorubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Disopyramide—Hypotension—Epirubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Disopyramide—Confusional state—Doxorubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Disopyramide—Oedema—Doxorubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Disopyramide—Shock—Doxorubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Disopyramide—Thrombocytopenia—Doxorubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Disopyramide—Insomnia—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Disopyramide—Skin disorder—Doxorubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Disopyramide—Paraesthesia—Epirubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Disopyramide—Hyperhidrosis—Doxorubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Disopyramide—Dyspnoea—Epirubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Disopyramide—Somnolence—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Disopyramide—Anorexia—Doxorubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Disopyramide—Dyspepsia—Epirubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Disopyramide—Decreased appetite—Epirubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Disopyramide—Hypotension—Doxorubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Disopyramide—Fatigue—Epirubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Disopyramide—Constipation—Epirubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Disopyramide—Pain—Epirubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Disopyramide—Insomnia—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Disopyramide—Paraesthesia—Doxorubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Disopyramide—Dyspnoea—Doxorubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Disopyramide—Feeling abnormal—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Disopyramide—Somnolence—Doxorubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Disopyramide—Dyspepsia—Doxorubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Disopyramide—Decreased appetite—Doxorubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Disopyramide—Fatigue—Doxorubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Disopyramide—Urticaria—Epirubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Disopyramide—Pain—Doxorubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Disopyramide—Constipation—Doxorubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Disopyramide—Body temperature increased—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Disopyramide—Feeling abnormal—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Disopyramide—Urticaria—Doxorubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Disopyramide—Body temperature increased—Doxorubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Disopyramide—Asthenia—Epirubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Disopyramide—Pruritus—Epirubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Disopyramide—Diarrhoea—Epirubicin—sarcoma	0.000981	0.000981	CcSEcCtD
Disopyramide—Asthenia—Doxorubicin—sarcoma	0.000951	0.000951	CcSEcCtD
Disopyramide—Dizziness—Epirubicin—sarcoma	0.000948	0.000948	CcSEcCtD
Disopyramide—Pruritus—Doxorubicin—sarcoma	0.000938	0.000938	CcSEcCtD
Disopyramide—Vomiting—Epirubicin—sarcoma	0.000911	0.000911	CcSEcCtD
Disopyramide—Diarrhoea—Doxorubicin—sarcoma	0.000907	0.000907	CcSEcCtD
Disopyramide—Rash—Epirubicin—sarcoma	0.000904	0.000904	CcSEcCtD
Disopyramide—Dermatitis—Epirubicin—sarcoma	0.000903	0.000903	CcSEcCtD
Disopyramide—Headache—Epirubicin—sarcoma	0.000898	0.000898	CcSEcCtD
Disopyramide—Dizziness—Doxorubicin—sarcoma	0.000877	0.000877	CcSEcCtD
Disopyramide—Nausea—Epirubicin—sarcoma	0.000851	0.000851	CcSEcCtD
Disopyramide—Vomiting—Doxorubicin—sarcoma	0.000843	0.000843	CcSEcCtD
Disopyramide—Rash—Doxorubicin—sarcoma	0.000836	0.000836	CcSEcCtD
Disopyramide—Dermatitis—Doxorubicin—sarcoma	0.000835	0.000835	CcSEcCtD
Disopyramide—Headache—Doxorubicin—sarcoma	0.000831	0.000831	CcSEcCtD
Disopyramide—Nausea—Doxorubicin—sarcoma	0.000788	0.000788	CcSEcCtD
